We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
951
Petrobras
PBR
$136B
$1.09M ﹤0.01%
106,326
JD icon
952
JD.com
JD
$36.4B
$1.09M ﹤0.01%
26,407
-64,380
-71% -$2.53M
IGF icon
953
iShares Global Infrastructure ETF
IGF
$10.3B
$1.09M ﹤0.01%
24,090
+1,130
+5% +$51.6K
JOUT icon
954
Johnson Outdoors
JOUT
$469M
$1.09M ﹤0.01%
17,508
-6,509
-27% -$455K
RMR icon
955
The RMR Group
RMR
$328M
$1.08M ﹤0.01%
18,147
+500
+3% +$28.1K
VNQI icon
956
Vanguard Global ex-US Real Estate ETF
VNQI
$3.38B
$1.07M ﹤0.01%
17,770
+4,500
+34% +$270K
EPAM icon
957
EPAM Systems
EPAM
$6.13B
$1.07M ﹤0.01%
10,000
EXTN
958
DELISTED
Exterran Corporation
EXTN
$1.07M ﹤0.01%
34,026
-21,488
-39% -$665K
CLVS
959
DELISTED
Clovis Oncology, Inc.
CLVS
$1.07M ﹤0.01%
15,700
-19,700
-56% -$1.38M
KMX icon
960
CarMax
KMX
$8.45B
$1.07M ﹤0.01%
16,640
-60
-0.4% -$4.28K
LMT icon
961
Lockheed Martin
LMT
$124B
$1.06M ﹤0.01%
3,306
AAOI icon
962
Applied Optoelectronics
AAOI
$8.36B
$1.06M ﹤0.01%
28,000
+4,200
+18% +$185K
ODP
963
DELISTED
ODP
ODP
$1.06M ﹤0.01%
29,880
-99,123
-77% -$3.43M
STLD icon
964
Steel Dynamics
STLD
$34.8B
$1.06M ﹤0.01%
24,501
+11,540
+89% +$444K
TLRD
965
DELISTED
Tailored Brands, Inc.
TLRD
$1.06M ﹤0.01%
+48,400
New +$813K
TG icon
966
Tredegar Corp
TG
$241M
$1.05M ﹤0.01%
54,880
+25,635
+88% +$491K
PBYI icon
967
Puma Biotechnology
PBYI
$475M
$1.05M ﹤0.01%
+10,647
New +$1.19M
MNTA
968
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.05M ﹤0.01%
75,400
+40,300
+115% +$545K
IMO icon
969
Imperial Oil
IMO
$63.2B
$1.05M ﹤0.01%
+33,573
New +$1.04M
EELV icon
970
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$430M
$1.04M ﹤0.01%
41,170
-3,070
-7% -$75.7K
EEMV icon
971
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
$1.03M ﹤0.01%
17,010
-2,030
-11% -$121K
PFG icon
972
Principal Financial Group
PFG
$25.4B
$1.03M ﹤0.01%
14,594
-6,700
-31% -$462K
USRT icon
973
iShares Core US REIT ETF
USRT
$4.4B
$1.03M ﹤0.01%
+20,740
New +$1.03M
UDR icon
974
UDR
UDR
$11.2B
$1.03M ﹤0.01%
26,642
+19,504
+273% +$758K
RIG icon
975
Transocean
RIG
$6.29B
$1.02M ﹤0.01%
96,000
-3,600
-4% -$37.4K

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.